| Welcome to Shield Of Islam. We hope you enjoy your visit. You're currently viewing our forum as a guest. This means you are limited to certain areas of the board and there are some features you can't use. If you join our community, you'll be able to access member-only sections, and use many member-only features such as customizing your profile, sending personal messages, and voting in polls. Registration is simple, fast, and completely free. Join our community! If you're already a member please log in to your account to access all of our features: |
| Nbc Analysis: Vioxx Verdict Won't Stop Lawsuits | |
|---|---|
| Tweet Topic Started: Nov 3 2005, 06:06 PM (119 Views) | |
| abuturab82 | Nov 3 2005, 06:06 PM Post #1 |
![]()
Administrator
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
|
NBC analysis: Vioxx verdict won't stop lawsuits NBC's Robert Bazell comments on Merck's victory in N.J. case NBC VIDEO Launch • Vioxx verdict Nov. 3: Drug maker Merck was found not responsible for a patient's heart attack in a N.J. lawsuit. NBC's Robert Bazell discusses the findings. MSNBC LIVE QUOTE SYMBOL LAST CHANGE % CHANGE • MRK 29.48 +1.07 +3.77% QUOTE LOOKUP Enter Company Symbol Enter Company Name Data: MSN Money and IDC Comstock delayed 20 min. Related Stories | What's this? • Key events in the development of Vioxx • Merck cleared in N.J. Vioxx trial • Second Vioxx trial under way in New Jersey • Closing arguments begin in second Vioxx trial • Second Vioxx trial gets off to rocky start Most Popular • Most Viewed • Top Rated • Most E-mailed • Brown joked in e-mail as Katrina churned • Fake journalism, real consequences • Customer glued to toilet seat sues Home Depot • Kidman ‘devastated’ about Cruise’s baby • Key al-Qaida figure reportedly captured • Most viewed on MSNBC.com • Stevie Wonder returns with love in his heart • Dead lab worker's records mean freedom to convicts • Weis honors dying boy by using his called play • Saved from the grave • 76-year-old man found after 18 days • Most viewed on MSNBC.com • Brown joked in e-mail as Katrina churned • Customer glued to toilet seat sues Home Depot • Vatican wants to end battle with science • Fake journalism, real consequences • Key al-Qaida figure reportedly captured • Most viewed on MSNBC.com MEDPAGE TODAY •Comprehensive Intervention Reduces Disability From Musculoskeletal Disorders •Frequent Oil Changes Linked to Rheumatoid Arthritis •Joint Finding: Family Suffers From Cartilage Peeling Syndrome •Upfront Combination Therapy Improves Early RA Symptoms Physicians... Earn CME with your medical news MSNBC Updated: 5:20 p.m. ET Nov. 3, 2005 Merck & Co. won a major victory Thursday in the battle over its Vioxx painkiller with a case that challenged whether the drug maker had misled consumers about the risks of the medication. A 60-year-old Idaho man charged that taking Vioxx for several months caused his heart attack four years ago and told lawyers that he would not have taken the painkiller if he had been informed of its risks. NBC's chief science correspondent Robert Bazell comments on the trial's impact. Q. A N.J. jury has found that the drug maker Merck properly warned consumers about the risks of its Vioxx painkiller. But in August a Texas jury found Merck liable in a Vioxx user’s death. How are the cases different? A. Different juries in different states. From the beginning of the case the New Jersey jurors showed more interest in the underlying science. And clearly Merck learned some lessons from its initial, enormous loss. Q. What impact could this verdict have on the thousands of similar lawsuits Merck is facing? A. Lawyers say it certainly won't stop them. But these trials are enormously expensive investments for the lawyers who bring them, and many will adapt a wait-and-see attitude during the next few cases to see whether a pattern emerges for or against the company. Story continues below ↓ advertisement Q. With all the attention being paid to the Vioxx cases, are doctors becoming more hesitant to prescribe painkillers? A. I have not heard that. Many people suffer severe pain from arthritis and similar ailments and they want relief. Related coverage * Do you agree with the verdict? * Jury findings | Key players | Chronology of events * Major victory for Merck in N.J. Vioxx trial Q. With Vioxx and other drugs like Bextra off the market, what other options do people suffering arthritis or chronic pain have now? A. One of the biggest lessons of the Vioxx episode has been that a lot of drugs are prescribed, not because they were necessarily better but because they were advertised heavily to doctors and patients. There is still one drug Celebrex in the same class on the market. And for many people there are many other pain relievers, including aspirin or Tylenol, that can be perfectly acceptable. © 2005 MSNBC Interactive |
![]() |
|
| 1 user reading this topic (1 Guest and 0 Anonymous) | |
| « Previous Topic · Current Events · Next Topic » |






![]](http://z2.ifrm.com/static/1/pip_r.png)




2:08 PM Jul 11